Free shipping on orders over $150

G1 Peptides

COMPARISON TOOL

Compare peptides

Half-life, dosing, mechanism, status — side by side. Select up to four compounds, or start from a preset.

Survodutide
Max 4 peptides
PropertySurvodutide
CategoryGLP-1
TypePeptide
MechanismDual glucagon / GLP-1 receptor agonist
StatusPhase 3
Dosing range0.6–4.8 mg weekly
FrequencyOnce weekly
Half-life~5–6 days (limited data)
RouteSubcutaneous
Onset2–4 weeks for appetite reduction
Studied for
  • Weight management
  • MASH / liver fat
Key risks
  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
StorageRefrigerated (2–8 °C); use within the pharmacy beyond-use date
Available at G1Not currently carried. Ask a provider
ToolsDosage calculator →

PROPERTY COMPARISON · RADAR

Profile shape

DurationQuick OnsetVersatilityTolerabilityUse CasesStackability
Editorial profile scores (0–10) for orientation — not clinical measurements.

TYPICAL DOSE RANGES

Dose envelope

Survodutide600 mcg – 4.8 mg

Typical per-dose range on a logarithmic scale. Your provider sets your dose.

For educational purposes only. Consult a licensed provider before starting any peptide protocol.